Live updates from the last day of the AACR Annual Meeting 2026, including plenaries on innovative treatment modalities and...
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
A recent study on the prevalence of cancer across different vertebrate species may provide insights into cancer mechanisms in...
At the AACR Conference on the Science of Cancer Health Disparities, researchers shared results from interventions designed to help...
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
This Halloween edition features ghostly transparent mice, parasites to deliver drugs to the brain, stealing from the dead, and...
The AACR Industry Roundtable 2024 focused on topics related to tracking and treating early cancers, including predicting cancer risk...
Janet Mosugu, recipient of the Margaret Foti Scholarship, wants to use communication to help empower communities take charge of...
The 16th Frontiers in Cancer Science conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Andrew Chapman and Kuang-Yi Wen of Thomas Jefferson University were named scientific awardees for their work in geriatric oncology...